Internal Medicine, Pulmonary Disease · Boston, MA
NPI
1750366977
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
330 Brookline Ave, Ksb-23/Bidmc
Boston, MA, 02215
Phone (617) 667-5864
Groups this clinician bills Medicare through
Medicare paid, 2024
$94K
2,025 services
Medicare patients, 2024
832
Average age 75
Drug cost, 2024
$2.8M
4,806 prescriptions
Company payments, 2025
$55.38
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Douglas M Beach was code 94010 (pulmonary function testing), 346 times for 302 patients. In total Douglas M Beach billed 2,025 services in 31 codes, and Medicare paid $94K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94010 Pulmonary Function Testing | Facility | 346 | 302 | $6.11 | $2,115 |
| 99214 Office E&M - Established | Facility | 313 | 277 | $73.34 | $23K |
| 99214 Office E&M - Established | Office | 246 | 206 | $75.21 | $19K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 239 | 206 | $13.64 | $3,261 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 133 | 121 | $13.60 | $1,808 |
| 94729 Pulmonary Function Testing | Facility | 103 | 101 | $6.62 | $682 |
| 99215 Office E&M - Established | Facility | 94 | 85 | $111.95 | $11K |
| 94010 Pulmonary Function Testing | Office | 90 | 64 | $24.76 | $2,228 |
| 99215 Office E&M - Established | Office | 50 | 40 | $114.48 | $5,724 |
| 99213 Office E&M - Established | Office | 48 | 47 | $54.19 | $2,601 |
| 95012 Pulmonary | Office | 36 | 35 | $17.73 | $638 |
| 94729 Pulmonary Function Testing | Office | 36 | 34 | $52.18 | $1,878 |
| 94726 Pulmonary Function Testing | Facility | 29 | 29 | $8.55 | $248 |
| 99205 Office E&M - New | Facility | 28 | 28 | $151.65 | $4,246 |
| 95811 Sleep Study | Facility | 28 | 28 | $97.73 | $2,736 |
By year: 2022 $78K for 1,574 services; 2023 $87K for 1,703 services; 2024 $94K for 2,025 services.
Medicare prescription drug claims, 2024
In 2024, the drug Douglas M Beach prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 603 prescriptions and refills. In total Douglas M Beach wrote 4,806 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 603 | 797 | 122 | $495K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 465 | 599 | 176 | $17K |
| Montelukast Sodium Generic | 398 | 1,020 | 113 | $5,832 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 346 | 556 | 86 | $336K |
| Azithromycin Generic | 305 | 347 | 116 | $2,402 |
| Prednisone Generic | 272 | 292 | 127 | $750 |
| Spiriva Respimat Tiotropium Bromide | 163 | 230 | 39 | $118K |
| Symbicort Budesonide/Formoterol Fumarate | 159 | 234 | 53 | $51K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 116 | 162 | 39 | $31K |
| Fluticasone Propionate Generic | 110 | 266 | 48 | $2,217 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 110 | 162 | 24 | $73K |
| Gabapentin Generic | 110 | 121 | 23 | $726 |
| Breo Ellipta Fluticasone/Vilanterol | 97 | 130 | 27 | $51K |
| Azelastine Hcl Generic | 96 | 176 | 32 | $3,809 |
| Nucala Mepolizumab | 76 | 76 | Under 11 | $280K |
Brand drugs: 2,734 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Douglas M Beach $55.38 ($55.38 in general payments such as food, travel and fees) from 2 companies. The largest payer was Inspire Medical Systems, Inc. with $38.53.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.